Treatment of micro air bubbles in rat adipose tissue at 25 kPa altitude exposures with perfluorocarbon emulsions and nitric oxide

[1]  M. Noble,et al.  What is the mechanism of flow‐mediated arterial dilatation , 2013, Clinical and experimental pharmacology & physiology.

[2]  O. Hyldegaard,et al.  Threshold altitude for bubble decay and stabilization in rat adipose tissue at hypobaric exposures. , 2013, Aviation, space, and environmental medicine.

[3]  B. Spiess,et al.  In vivo microvascular mosaics show air embolism reduction after perfluorocarbon emulsion treatment. , 2012, Microvascular research.

[4]  O. Hyldegaard,et al.  Effect of oxygen breathing on micro oxygen bubbles in nitrogen-depleted rat adipose tissue at sea level and 25 kPa altitude exposures. , 2012, Journal of applied physiology.

[5]  J. Briceño,et al.  Perfluorocarbon-based oxygen carriers: review of products and trials. , 2010, Artificial organs.

[6]  O. Hyldegaard,et al.  Effect of oxygen breathing and perfluorocarbon emulsion treatment on air bubbles in adipose tissue during decompression sickness. , 2009, Journal of applied physiology.

[7]  B. Spiess.  The Physiology and Pathophysiology of the Hyperbaric and Diving Environments Perfluorocarbon emulsions as a promising technology : a review of tissue and vascular gas dynamics , 2009 .

[8]  O. Hyldegaard,et al.  Effect of oxygen and heliox breathing on air bubbles in adipose tissue during 25-kPa altitude exposures. , 2008, Journal of applied physiology.

[9]  O. Hyldegaard,et al.  Effect of hypobaric air, oxygen, heliox (50:50), or heliox (80:20) breathing on air bubbles in adipose tissue. , 2007, Journal of applied physiology.

[10]  H. Dainer,et al.  Short oxygen prebreathing and intravenous perfluorocarbon emulsion reduces morbidity and mortality in a swine saturation model of decompression sickness. , 2007, Journal of applied physiology.

[11]  D. Eckmann,et al.  Influence of Endothelial Glycocalyx Degradation and Surfactants on Air Embolism Adhesion , 2006, Anesthesiology.

[12]  U. Wisløff,et al.  Effect of a short-acting NO donor on bubble formation from a saturation dive in pigs. , 2006, Journal of applied physiology.

[13]  U. Wisløff,et al.  Exogenous nitric oxide and bubble formation in divers. , 2006, Medicine and science in sports and exercise.

[14]  M. Schiavon,et al.  Delayed effect of nitric oxide synthase inhibition on the survival of rats after acute decompression. , 2005, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[15]  J. Riess,et al.  Understanding the Fundamentals of Perfluorocarbons and Perfluorocarbon Emulsions Relevant to In Vivo Oxygen Delivery , 2005, Artificial cells, blood substitutes, and immobilization biotechnology.

[16]  J. T. Webb,et al.  Altitude decompression sickness symptom resolution during descent to ground level. , 2004, Aviation, space, and environmental medicine.

[17]  David M. Dromsky,et al.  Treatment of decompression sickness in swine with intravenous perfluorocarbon emulsion. , 2004, Aviation, space, and environmental medicine.

[18]  Alf O Brubakk,et al.  Exercise and nitric oxide prevent bubble formation: a novel approach to the prevention of decompression sickness? , 2004, The Journal of physiology.

[19]  U. Wisløff,et al.  Nos inhibition increases bubble formation and reduces survival in sedentary but not exercised rats , 2003, The Journal of physiology.

[20]  Y. Melamed,et al.  Effect of combined recompression and air, oxygen, or heliox breathing on air bubbles in rat tissues. , 2001, Journal of applied physiology.

[21]  P. Keipert,et al.  Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy Volunteers , 2000 .

[22]  T S Dart,et al.  Towards new paradigms for the treatment of hypobaric decompression sickness. , 1998, Aviation, space, and environmental medicine.

[23]  Philip P. Foster,et al.  Role of metabolic gases in bubble formation during hypobaric exposures. , 1998, Journal of applied physiology.

[24]  T. Langø,et al.  Diffusion coefficients and solubility coefficients for gases in biological fluids and tissues: a review. , 1996, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[25]  M. Burkard,et al.  Simulation of exchanges of multiple gases in bubbles in the body. , 1994, Respiration physiology.

[26]  B. Spiess.  Perfluorocarbon Emulsions: One Approach to Intravenous Artificial Respiratory Gas Transport , 1994, International anesthesiology clinics.

[27]  M. Burkard,et al.  The oxygen window and decompression bubbles: estimates and significance. , 1993, Aviation, space, and environmental medicine.

[28]  H. Fung,et al.  Pharmacokinetic/pharmacodynamic relationship of the duration of vasodilating action of organic mononitrates in rats. , 1992, Journal of Pharmacology and Experimental Therapeutics.

[29]  O. Hyldegaard,et al.  Effect of He-O2, O2, and N2O-O2 breathing on injected bubbles in spinal white matter. , 1991, Undersea biomedical research.

[30]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[31]  T. Shaffer,et al.  Effects of intravenous perfluorocarbon and oxygen breathing on acute decompression sickness in the hamster. , 1989, Undersea biomedical research.

[32]  O. Hyldegaard,et al.  Influence of heliox, oxygen, and N2O-O2 breathing on N2 bubbles in adipose tissue. , 1989, Undersea biomedical research.

[33]  J. Abrams.  Hemodynamic effects of nitroglycerin and long-acting nitrates. , 1985, American heart journal.

[34]  J. Lutz,et al.  Perfluorochemicals as a treatment of decompression sickness in rats , 1984, Pflügers Archiv.

[35]  Homer Ld,et al.  Solubility of inert gases in biological fluids and tissues: a review. , 1980 .

[36]  J. Madsen,et al.  Continuous estimation of adipose tissue blood flow in rats by 133Xe elimination. , 1975, Journal of applied physiology.

[37]  K. Ward,et al.  Intravenous perfluorocarbon emulsion increases nitrogen washout after venous gas emboli in rabbits. , 2007, Undersea & Hyperbaric Medicine.

[38]  H. Dainer,et al.  Decompression sickness in a swine model: isobaric denitrogenation and perfluorocarbon at depth. , 2006, Aviation, space, and environmental medicine.

[39]  P. Keipert,et al.  Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. , 2000, Anesthesia and analgesia.

[40]  M. Burkard,et al.  Simulation of gas bubbles in hypobaric decompressions: roles of O2, CO2, and H2O. , 1995, Aviation, space, and environmental medicine.

[41]  S. Flaim.  Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[42]  B. Spiess,et al.  Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43). , 1988, Undersea biomedical research.

[43]  K. Lowe,et al.  Perfluorocarbons as oxygen-transport fluids. , 1987, Comparative biochemistry and physiology. A, Comparative physiology.

[44]  P. Weathersby,et al.  Solubility of inert gases in biological fluids and tissues: a review. , 1980, Undersea biomedical research.